“Durable complete response in a patient with BRAF-mutated advanced melanoma with ocular and skin toxicities from BRAF/MEK targeted therapy after immune checkpoint inhibitor treatment: a case report”, Dermatol Reports, Jun. 2025, doi: 10.4081/dr.2025.10324.